Insert and label provisions (SFDA Order 24)
Provisions for Drug Insert Sheets and Labels
药品说明书和标签管理规定
Summary
The detailed Chinese rules for inserts and labels: content approved by NMPA, no content beyond the insert, generic name prominence over the trade name, items on inner and outer labels, and minimum items for small inner labels.
More in the full catalogue
Key labelling requirements (4), transition and timeline notes, related documents and CSV export are available to testers.
Sign in · Register
Relevance by packaging component
| Component | Relevance | What it concerns |
|---|---|---|
| CartonOuter packaging / folding carton | D Direct | |
| LabelImmediate container label (bottle, tube, large vial, bag) | D Direct | |
| Blister / foilBlisters, strips, sachets, lidding foil | D Direct | |
| Small unitSmall immediate packaging: ampoule, small vial, cartridge, pen | D Direct | |
| LeafletPackage leaflet / PIL, package insert, prescribing information, Medication Guide | D Direct | |
| DeviceIntegral or co-packaged device and its instructions for use | – | |
| Shipper / caseTertiary packaging: shipping case, homogeneous case, pallet | – | |
| e-LabellingElectronic product information, QR / 2D-code linked content | – |
packart.dev summary, not a quotation of the source. Confirm requirements in the official text before regulatory use.